# AbbVie Inc. (ABBV) — Q3-2017 Earnings Results

**Report date:** 2017-10-27 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2017

## Post-Earnings Brief

### Headline

AbbVie Misses on EPS, Stock Up 2.65%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.41 | N/A | -0.11% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in their product pipeline, suggesting it will support long-term growth. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> Management highlighted ongoing efforts to drive growth through innovation.

> They emphasized the importance of their pipeline in sustaining future revenue.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a slight miss on EPS, but the stock reacted positively, rising 2.65%. Investors may be encouraged by management's focus on innovation and the potential of their product pipeline, despite the lack of specific guidance. The overall sentiment appears to be cautiously optimistic as the company navigates its growth strategy.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2017_